Healthcare -
Medical - Devices - NASDAQ - US
$ 0.9553
3.4 %
$ 56.7 M
Market Cap
-0.85
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Lucid Diagnostics Inc.
| Net Income | -52.7 M |
| Depreciation & Amortization | 2.5 M |
| Capital Expenditures | -221 K |
| Stock-Based Compensation | 6.82 M |
| Change in Working Capital | 5.68 M |
| Others | 10.5 M |
| Free Cash Flow | -33 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (52.7) | (56.2) | (28.1) | (8.3) | (4.4) | (1.1) |
| Depreciation & Amortization | 2.5 | 1.9 | 4 K | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | (10.5) | 0 | 0 | 0 |
| Stock Based Compensation | 6.8 | 15.0 | 9.6 | 65 K | 0.2 | 79.8 K |
| Other Operating Activities | 4.9 | 0.7 | 10.5 | (1.1) | (0.1) | (0.2) |
| Change in Working Capital | 5.7 | 8.9 | 0.8 | 2.6 | 1.9 | 0.7 |
| Cash From Operations | (32.8) | (29.7) | (17.7) | (5.6) | (2.4) | (0.1) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (0.2) | (0.9) | (0.9) | 0 | 0 | 0 |
| Other Items | 0 | (3.2) | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (0.2) | (4.1) | (0.9) | 0 | 0 | 0 |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 10.0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 19.2 | 0.8 | 2.1 | 5.6 | 2.5 | 0.1 |
| Cash From Financing Activities | 29.5 | 2.6 | 72.1 | 5.6 | 2.5 | 0.1 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (3.6) | (31.2) | 53.5 | 45.1 K | 0.1 | 17.8 K |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (33.0) | (30.6) | (18.5) | (5.6) | (2.4) | (0.1) |